Who owns the OPIPZA trademark?

The OPIPZA trademark is owned by LP Pharmaceuticals, Inc.

What class is the OPIPZA trademark registered in?

The OPIPZA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for OPIPZA?

The USPTO serial number for OPIPZA is 98484528.

What is the registration number for OPIPZA?

OPIPZA is registered under USPTO registration number 7893484.

Sealvo

Home Search: OPIPZAOPIPZA #98484528

Back

Updated Sep 28, 2026·29 searches this week

View on USPTO TSDR Find similar marks

OPI

USPTO Trademark Record

REGISTERED

OPIPZA

SN 98484528·Reg 7893484·Filed Apr 04, 2024

Owner LP Pharmaceuticals, Inc

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

OPIPZA (Serial No. 98484528), Registration No. 7893484, is a registered US trademark filed on Apr 04, 2024 by LP Pharmaceuticals, Inc. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: August 12, 2031

Conflict Analysis

Full conflict analysis for OPIPZA (SN 98484528) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

OPIPZA (Reg. #7893484) is a registered US trademark that has been protecting its owner, LP Pharmaceuticals, Inc, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 04, 2024

SERIAL

98484528

REG#

7893484

REGISTERED

Aug 12, 2025

Filing Information

StatusREGISTERED

Filing DateApr 04, 2024

Serial Number98484528

Registration No.7893484

Registration DateAug 12, 2025

Status DateAug 12, 2025

Published for OppositionDec 17, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Nov 05, 2024

First use in commerce: Mar 20, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

31 events

REGISTERED-PRINCIPAL REGISTER

Aug 12, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 12, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 22, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 22, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ASSIGNED TO LIE

Jul 17, 2025

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 17, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 17, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 07, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Jul 02, 2025

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Jul 02, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 02, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 28, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Jun 28, 2025

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Mar 26, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Mar 26, 2025

USE AMENDMENT FILED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Mar 25, 2025

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

WITHDRAWAL OF ATTORNEY GRANTED

Mar 25, 2025

WITHDRAWAL OF ATTORNEY GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 11, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 17, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 17, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 11, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 20, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 16, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 16, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 16, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Oct 18, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 18, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 18, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 17, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Apr 04, 2024

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 04, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by LP Pharmaceuticals, Inc

Additional USPTO filings from the same owner.

IRY

IRYYX

99224754

LP Pharmaceuticals, Inc

REGISTERED

PUR

PURA-MER

98808856

LP Pharmaceuticals, Inc

PENDING

PSO

PSOTRA

99224837

LP Pharmaceuticals, Inc

PENDING

VIQ

VIQUR

99218716

LP Pharmaceuticals, Inc

PENDING

OPIPZA

Run a conflict check

Other Marks by LP Pharmaceuticals, Inc

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company